|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/12 | (2006.01) |
| A61K 31/517 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1667992 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04768483.2 |
| Date of filing the European patent application | 2004-09-15 | |
| (97) | Date of publication of the European application | 2006-06-14 |
| (45) | Date of publication and mention of the grant of the patent | 2007-01-24 |
| (46) | Date of publication of the claims translation | 2007-04-25 |
| (86) | Number | PCT/GB2004/003937 |
| Date | 2004-09-15 |
| (87) | Number | WO 2005/028469 |
| Date | 2005-03-31 |
| (30) | Number | Date | Country code |
| 03292309 | 2003-09-19 | EP | |
| 04291248 | 2004-05-14 | EP |
| (72) |
BRADBURY, Robert Hugh AstraZeneca R & D Alderley, GB
HENNEQUIN, Laurent Francois Andre, FR
BARLAAM, Bernard Christophe, AstraZeneca Pharma, FR
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Chinazolino dariniai |
| QUINAZOLINE DERIVATIVES |
| Payment date | Validity (years) | Amount | |
| 2018-08-23 | 15 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2019-09-15 |